Publications by authors named "R de Mercato"

The purpose of our study was to describe the results of a seroprevalence survey for HCV antibody among health care workers at our center. 961 specimens were consecutively obtained under code and screened for anti-HCV by the second generation immunoblot assay (RIBA 2) and hepatitis B core antibody by CORAB test. After serum samples were tested, we reviewed demographic data and categorized four groups: intravenous drug abusers (IVDAs), blood recipients, health care workers and apparently healthy subjects.

View Article and Find Full Text PDF

To determine the transmission of hepatitis C in family members of chronic carriers we study the results of a HCV seroprevalence among spouses and children living together with patients affected by HCV related chronic liver disease. Seroprevalence of HCV antibodies and mean cohabitation time was determined among 54 index patients, their 54 spouses and 99 children. Twelve spouses (22.

View Article and Find Full Text PDF

1. Chylomicron remnants, the intermediate intestinal lipoproteins carrying the bulk of dietary cholesterol, are actively taken up and degraded in the hepatocytes, releasing cholesterol which can be excreted in bile. To study this pathway, a mass of remnants, leading to a consistent rise in hepatic cholesterol, was administered as an intravenous bolus in rats with chronic bile fistula equilibrated by water, electrolyte and taurocholate infusions, and changes in biliary lipids and bile acids were evaluated for up to 24 h in comparison with baseline.

View Article and Find Full Text PDF

It is known that ascorbate has a lipid lowering effect, accompanied by a drop of apo B, in rats fed a diet enriched with 1.5% of cholesterol (Nath diet). In order to better clarify the role exerted by ascorbate in lipid metabolism, the effect of ascorbate administration on apolipoprotein pattern in rats fed the Nath diet was investigated.

View Article and Find Full Text PDF

The purpose of this study was to assess the epidemiology of hepatitis C virus (HCV) in prisoners and outpatients attending our center. 2205 specimens were consecutively obtained under code and screened for anti-HCV by the second generation RIBA test and Hepatitis B core antibody (HBcAb) by CORAB test. After serum samples were tested, we reviewed demographic data and categorized four groups: Intravenous drug abusers (IVDAs), prisoners and apparently healthy subjects and warders.

View Article and Find Full Text PDF